ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder

被引：15
|
作者：
Marino, Ryan [1 ]
Perrone, Jeanmarie [2 ]
Nelson, Lewis S. [3 ]
Wiegand, Timothy J. [4 ]
Schwarz, Evan S. [5 ]
Wax, Paul M. [6 ]
Stolbach, Andrew I. [7 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Rutgers New Jersey Med Sch, Newark, NJ USA
[4] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[5] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA
[6] Univ Texas Southwestern, Dallas, TX USA
[7] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF MEDICAL TOXICOLOGY | 2019年 / 15卷 / 04期
关键词：
Buprenorphine; Waiver; X-waiver; Opioid use disorder; Opioid agonist therapy; METHADONE; DEATHS;
D O I：
10.1007/s13181-019-00728-9
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
[No abstract available]
引用
收藏
页码：307 / 309
页数：3
相关论文
共 50 条
  • [1] ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder
    Ryan Marino
    Jeanmarie Perrone
    Lewis S. Nelson
    Timothy J. Wiegand
    Evan S. Schwarz
    Paul M. Wax
    Andrew I. Stolbach
    [J]. Journal of Medical Toxicology, 2019, 15 : 307 - 309
  • [2] ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
    Ryan T. Marino
    Meghan Spyres
    Timothy J. Wiegand
    Kavita M. Babu
    Andrew Stolbach
    [J]. Journal of Medical Toxicology, 2022, 18 : 71 - 73
  • [3] ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
    Marino, Ryan T.
    Spyres, Meghan
    Wiegand, Timothy J.
    Babu, Kavita M.
    Stolbach, Andrew
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2022, 18 (01) : 71 - 73
  • [4] ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
    Stolbach, Andrew
    Mazer-Amirshahi, Maryann
    Schwarz, Evan S.
    Juurlink, David
    Wiegand, Timothy J.
    Nelson, Lewis S.
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2020, 16 (04) : 484 - 486
  • [5] ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
    Andrew Stolbach
    Maryann Mazer-Amirshahi
    Evan S. Schwarz
    David Juurlink
    Timothy J. Wiegand
    Lewis S. Nelson
    [J]. Journal of Medical Toxicology, 2020, 16 : 484 - 486
  • [6] ACMT Position Statement: Buprenorphine Administration in the Emergency Department
    Paul M. Wax
    Andrew I. Stolbach
    Evan S. Schwarz
    Brandon J. Warrick
    Timothy J. Wiegand
    Lewis S. Nelson
    [J]. Journal of Medical Toxicology, 2019, 15 : 215 - 216
  • [7] ACMT Position Statement: Buprenorphine Administration in the Emergency Department
    Wax, Paul M.
    Stolbach, Andrew I.
    Schwarz, Evan S.
    Warrick, Brandon J.
    Wiegand, Timothy J.
    Nelson, Lewis S.
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2019, 15 (03) : 215 - 216
  • [8] Common Misperceptions About Buprenorphine Prescribing for Opioid Use Disorder
    Martin, Stephen A.
    Chiodo, Lisa M.
    Wilson, Amanda
    [J]. AMERICAN FAMILY PHYSICIAN, 2019, 100 (07) : 396 - 397
  • [9] Improving Access to Pediatric Opioid Use Disorder Treatment With Buprenorphine Waiver Training
    Bayner, Jessica
    Ignaszewski, Martha
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 240 - 241
  • [10] Common Elements in Opioid Use Disorder Guidelines for Buprenorphine Prescribing
    Atkinson, Timothy J.
    Pisansky, Andrew J. B.
    Miller, Katie L.
    Yong, R. Jason
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (03): : E88 - +
12345